XClose

UCL School of Pharmacy

Home
Menu

World’s first study to manufacture and dispense 3D printed personalised medicines for patients

5 February 2025

Researchers from the Basit Research Group, based at UCL School of Pharmacy, and FABRX, a UCL School of Pharmacy spinout, have just published the World’s first study on producing and dispensing personalised medicines by pharmaceutical 3D printing in a community pharmacy in Madrid.

Picture of the M3DIMAKER 1 pharmaceutical 3D printer setup in the community pharmacy for production and dispensing of personalised minoxidil medicines.

A successful collaboration between UCL School of Pharmacy researchers from the Basit Research Group and FABRX as well as University of Santiago de Compostela has published the world’s first study on automatic compounding and dispensing of medicines in a community pharmacy using pharmaceutical 3D printing. In the study, minoxidil medicines were both produced and dispensed to patients within the community pharmacy, creating an automatic process for personalised dosing. Proving the feasibility of 3D printing and automated dispensing of personalised medicines within a retail pharmacy setting will undoubtedly serve as a milestone in the journey towards more patient-tailored medications. The study will transform the traditional ways of treatment whilst providing pharmacists with an automated tool to expedite and enhance the control of compounding medicines at the point of care.

To read the publication, please visit: https://doi.org/10.1016/j.ijpharm.2025.125251

For any queries or more information, please contact Professor Abdul Basit (a.basit@ucl.ac.uk) or Dr Alvaro Goyanes (a.goyanes@fabrx.co.uk)